Molecular Mechanisms of Intervertebral Disc Degeneration Induced by Propionibacterium acnes
BioMed Research International · 2025
DOI: 10.1155/bmri/5513856 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioMed Research International, 2025. Verfasst von Weichao Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangzhou Red Cross Hospital, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China. Hauptthemen laut MEDLINE: Propionibacterium acnes, Intervertebral Disc Degeneration, Gram-Positive Bacterial Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Planning Project of Guangdong Province, Guangzhou Science and Technology Program key projects.
Abstract (Originalsprache)
Intervertebral disc degeneration (IVDD), a prevalent degenerative disorder with substantial socioeconomic impacts, is closely linked to endplate inflammation and chronic low back pain. Its pathogenesis involves multifactorial mechanisms, including long‐term chronic mechanical loading, external trauma, and hereditary factors. Emerging evidence highlights Propionibacterium acnes ( P. acnes ), a gram‐positive bacterium with potent proinflammatory properties, as a key contributor to IVDD progression. This review systematically analyses the latest literature on related studies, focusing on the molecular mechanisms of IVDD induced by P. acnes . Three molecules play an important role in the induction of IVDD by P. acnes , namely, IL‐1 β , MIF, and MMP. In addition, P. acnes induces IVDD through three core mechanisms, namely, proinflammatory (activation of TLR2, production of large amounts of ROS to promote inflammation), pyroptosis (production of large amounts of NLRP3 through the TXNIP‐NLRP3 axis and the ROS‐NLRP3 axis), and apoptosis (promotion of Bax and inhibition of Bcl‐2 expression through the TLR2‐JNK pathway). The dissection of these related important molecules and pathogenic mechanisms can lead to a better understanding of the role of P. acnes in IVDD. It can provide an important theoretical basis for future research. However, the current study’s lack of large‐scale clinical validation, unresolved colonization controversies, and limited experimental methods are limitations. Therefore, in the future, it is still necessary to improve the relevant theories and resolve the current controversies through more advanced experimental methods and higher quality clinical studies. In conclusion, the study of P. acnes –induced IVDD is promising, and further research can be conducted in the future, which is expected to develop novel therapeutic approaches for P. acnes , thus effectively slowing down the development of IVDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangzhou Red Cross Hospital, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
- Department of Pain Medicine, Guangzhou Red Cross Hospital, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, China.
ORCID-Profile: Weichao Yang, Haixiong Miao, Dongping Ye
Förderung
- Science and Technology Planning Project of Guangdong Province
- Guangzhou Science and Technology Program key projects
Zitieren
APA
Yang, W., Xu, Y., Tan, Y., Lin, J., Chen, H., Li, S., Miao, H., & Ye, D. (2025). Molecular Mechanisms of Intervertebral Disc Degeneration Induced by Propionibacterium acnes. BioMed Research International. https://doi.org/10.1155/bmri/5513856
Vancouver
Yang W, Xu Y, Tan Y, Lin J, Chen H, Li S, et al. Molecular Mechanisms of Intervertebral Disc Degeneration Induced by Propionibacterium acnes. BioMed Research International. 2025. doi:10.1155/bmri/5513856
BibTeX
@article{Yang2025,
author = {Yang, Weichao and Xu, Yude and Tan, Yong and Lin, Jinzhi and Chen, Huan and Li, Shaojin and Miao, Haixiong and Ye, Dongping},
title = {Molecular Mechanisms of Intervertebral Disc Degeneration Induced by Propionibacterium acnes},
journal = {BioMed Research International},
year = {2025},
doi = {10.1155/bmri/5513856}
}
EUVIMED